Literature DB >> 29740166

Triggering and resolution of inflammation in NASH.

Susanne Schuster1, Daniel Cabrera2,3, Marco Arrese2,4, Ariel E Feldstein5.   

Abstract

Nonalcoholic steatohepatitis (NASH) is considered the progressive form of nonalcoholic fatty liver disease (NAFLD) and is characterized by liver steatosis, inflammation, hepatocellular injury and different degrees of fibrosis. A central issue in this field relates to the identification of those factors that trigger inflammation, thus fuelling the transition from nonalcoholic fatty liver to NASH. These triggers of liver inflammation might have their origins outside the liver (such as in adipose tissue or the gut) as well as inside the organ (for instance, lipotoxicity, innate immune responses, cell death pathways, mitochondrial dysfunction and endoplasmic reticulum stress), both of which contribute to NASH development. In this Review, we summarize the currently available information on the key upstream triggers of inflammation in NASH. We further delineate the mechanisms by which liver inflammation is resolved and the implications of a defective pro-resolution process. A better knowledge of these mechanisms should help to design targeted therapies able to halt or reverse disease progression.

Entities:  

Mesh:

Year:  2018        PMID: 29740166     DOI: 10.1038/s41575-018-0009-6

Source DB:  PubMed          Journal:  Nat Rev Gastroenterol Hepatol        ISSN: 1759-5045            Impact factor:   46.802


  157 in total

1.  Inhibition of hyaluronan synthesis by 4-methylumbelliferone ameliorates non-alcoholic steatohepatitis in choline-deficient L-amino acid-defined diet-induced murine model.

Authors:  Yoon Mee Yang; Zhijun Wang; Michitaka Matsuda; Ekihiro Seki
Journal:  Arch Pharm Res       Date:  2021-01-24       Impact factor: 4.946

2.  Expression of STING Is Increased in Liver Tissues From Patients With NAFLD and Promotes Macrophage-Mediated Hepatic Inflammation and Fibrosis in Mice.

Authors:  Xianjun Luo; Honggui Li; Linqiang Ma; Jing Zhou; Xin Guo; Shih-Lung Woo; Ya Pei; Linda R Knight; Michael Deveau; Yanming Chen; Xiaoxian Qian; Xiaoqiu Xiao; Qifu Li; Xiangbai Chen; Yuqing Huo; Kelly McDaniel; Heather Francis; Shannon Glaser; Fanyin Meng; Gianfranco Alpini; Chaodong Wu
Journal:  Gastroenterology       Date:  2018-09-10       Impact factor: 22.682

3.  Response to the letter by Sumida et al. regarding our manuscript "Evaluation of ballooned hepatocytes as a risk factor for future progression of fibrosis in patients with non-alcoholic fatty liver disease".

Authors:  Keisuke Kakisaka; Yuji Suzuki; Yudai Fujiwara; Tamami Abe; Miki Yonezawa; Hidekatsu Kuroda; Kazuyuki Ishida; Tamotsu Sugai; Yasuhiro Takikawa
Journal:  J Gastroenterol       Date:  2019-03-26       Impact factor: 7.527

4.  Lipid droplet-associated kinase STK25 regulates peroxisomal activity and metabolic stress response in steatotic liver.

Authors:  Annika Nerstedt; Yeshwant Kurhe; Emmelie Cansby; Mara Caputo; Lei Gao; Egor Vorontsov; Marcus Ståhlman; Esther Nuñez-Durán; Jan Borén; Hanns-Ulrich Marschall; Douglas G Mashek; Darren N Saunders; Carina Sihlbom; Andrew J Hoy; Margit Mahlapuu
Journal:  J Lipid Res       Date:  2019-12-19       Impact factor: 5.922

Review 5.  Gut microbiota in non-alcoholic fatty liver disease and alcohol-related liver disease: Current concepts and perspectives.

Authors:  Juan P Arab; Marco Arrese; Vijay H Shah
Journal:  Hepatol Res       Date:  2020-01-13       Impact factor: 4.288

6.  Predicting Non-Alcoholic Fatty Liver Disease Progression and Immune Deregulations by Specific Gene Expression Patterns.

Authors:  Fanhong Zeng; Yue Zhang; Xu Han; Min Zeng; Yi Gao; Jun Weng
Journal:  Front Immunol       Date:  2021-01-26       Impact factor: 7.561

Review 7.  The Matrisome, Inflammation, and Liver Disease.

Authors:  Christine E Dolin; Gavin E Arteel
Journal:  Semin Liver Dis       Date:  2020-01-07       Impact factor: 6.115

Review 8.  Lytic cell death in metabolic liver disease.

Authors:  Jérémie Gautheron; Gregory J Gores; Cecília M P Rodrigues
Journal:  J Hepatol       Date:  2020-04-13       Impact factor: 25.083

Review 9.  Role of cAMP and phosphodiesterase signaling in liver health and disease.

Authors:  Banrida Wahlang; Craig McClain; Shirish Barve; Leila Gobejishvili
Journal:  Cell Signal       Date:  2018-06-11       Impact factor: 4.315

Review 10.  Nonalcoholic steatohepatitis: the role of peroxisome proliferator-activated receptors.

Authors:  Sven Francque; Gyongyi Szabo; Manal F Abdelmalek; Christopher D Byrne; Kenneth Cusi; Jean-François Dufour; Michael Roden; Frank Sacks; Frank Tacke
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-10-22       Impact factor: 46.802

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.